FDA’s OGD Takes Fight To COVID-19 With Half-Century Of Approvals

Six-Dozen First Generics Approved Last Year Including $3.3bn Tecfidera

 
• By Dean Rudge
  
FDA entrance sign 2016
Generic sponsors worked on antibiotics, sedatives used in ventilated patients, anticoagulants, and pulmonary medications for COVID-19 use • Source: Shutterstock

More from Products

More from Generics Bulletin